DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Midodrine
Midodrine
Anti-Hypotensive Effects of M6434, an Orally Active a 1-Adrenoceptor Agonist, in Rats
Effectiveness of Midodrine Treatment in Patients with Recurrent Vasovagal
Drugs-Biologicals FORMULARY for INTERNET PAGE 12 26 18
Midodrine As Adjunctive Support for Treatment of Refractory Hypotension
Droxidopa (NORTHERA) Drug Monograph
Practical Approaches for the Treatment of Chronic Heart Failure: Frequently Asked Questions, Overlooked Points and Controversial Issues in Current Clinical Practice
OUH Formulary Approved for Use in Breast Surgery
Droxidopa (Northera®) EOCCO POLICY
Proamatine (Midodrine Hydrochloride)
2000 Dialysis of Drugs
The Toxicology Investigators Consortium Case Registry—The 2019 Annual Report
Mar-Midodrine
Appendix B - Product Name Sorted by Applicant
Midodrine Monitoring Guidance
2021 Equine Prohibited Substances List
Drug/Substance Trade Name(S)
United Mine Workers of America Health and Retirement Funds 2021
MIDODRINE Introduction Midodrine Is a Peripherally Acting Alpha-1
Top View
Adjusting Droxidopa for Neurogenic Orthostatic Hypotension in a Patient with Parkinson Disease
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Adrenergic Agents
Lancreotide/Octreotide POTS New Medicine Recommendation
Australasian Anaesthesia 2019
Drug-Resin Complexes Stabilized by Chelating Agents
NHS Kent and Medway
Effects of Midodrine Hydrochloride on Blood Pressure and Cerebral Blood Flow During Orthostasis in Persons with Chronic Tetraplegia Jill M
Potential Risks in Using Midodrine for Persistent Hypotension After Cardiac
Guidelines for Drug Therapy in Pediatric Patients with Cardiovascular Diseases (JCS 2012) – Digest Version – JCS Joint Working Group
An Inventory of Medicinal Products Causing Skin Rash: Clinical and Regulatory Lessons
Effect of Alpha-1-Adrenergic Agonist, Midodrine for the Management of Long-Standing Neurogenic Shock in Patient with Cervical Spinal Cord Injury: a Case Report
Vasopressor-Sparing Strategies in Patients with Shock: a Scoping-Review and an Evidence-Based Strategy Proposition
2020 Medi-Cal
Vasopressors and Inotropes in Shock 2019
WO 2013/057579 A2 25 April 2013 (25.04.2013) P O P C T
New Zealand Data Sheet 1
Topically Applied Midodrine, 0.2%, an Α1-Agonist, for the Treatment Of
FDA Briefing Document on Cardiovascular and Renal Drugs
Midodrine Information Leaflet
Midodrine for the Treatment of Refractory Hypotension
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
A Case of a Dispensing Error Causing Iatrogenic Orthostatic Hypotension by Kenneth Lam, Ann Leung, and Trevor Jaimeson
Midodrine Prescribing Guidelines
Pocket Guide to Critical Care Pharmacotherapy Pocket Guide to Critical Care Pharmacotherapy
QT Prolongation
Risk Assessment and Risk Mitigation Review(S)
CVS Caremark® Value Formulary Effective As of 07/01/2021
Midodrine As Adjunctive Support for Treatment of Refractory Hypotension in the Intensive Care Unit
Title 16. Crimes and Offenses Chapter 13. Controlled Substances Article 1
Treatment of Bipolar Disorders Chapter 14. Mood
Etilefrine Could Improve Response to Standard Medical Therapy in Chronic Hepatitis C Egyptian Patients with Cirrhotic Refractory Ascites: a Randomized Pilot Study
Therapeutic Drug Class
PRIOR AUTHORIZATION CRITERIA for APPROVAL Northera (Droxidopa) – INITIAL Evaluation Will Be Approved When ALL of the Following Are Met: 1
Identification of Applicable 6-Digit HS Subheadings for Products Covered by the Proposed Uruguay Round Pharmaceutical Agreement
(12) United States Patent (10) Patent No.: US 7,838,552 B2 Davis Et Al
Midodrine Hydrochloride and the Treatment of Orthostatic Hypotension in Tetraplegia: Two Cases and a Review of the Literature
2016 AGSC DRUG TESTING LIST RCI Class 1 Drugs
Effect of Adjunct Midodrine on Length of Stay in Vasopressor
The Canadian Anti-Doping Program
STARS CANADA Midodrine FACT Sheet.Indd
STARS Midodrine FACT Sheet.Indd